-
NMPA Issued the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim)
2019-12-20
NMPA has organized the formulation of the Guidelines for Clinical Trials of Drugs for Treatment of Nonalcoholic Steatohepatitis (Interim), which was released on December 20, 2019.
-
NMPA Issued the Notice on Enabling the Import and Export Permit Management System
2019-12-27
NMPA issued the Notice on Enabling the Import and Export Permit Management System, which clearly states that the drug import and export permit management system has been officially launched since December 25, 2019.
-
NMPA issued the Announcement on Enabling the Pharmaceutical Business Application System
2019-12-31
NMPA has integrated the development of a drug business application system to this end,covering the certificates for drug export sales,APIs exporting to EU drug substance,import and export of narcotic drugs and psychotropic substances,and the initial import of medicinal materials,etc.
-
NMPA Issued the Guidelines for Adverse Event Classification Standards for Clinical Trials of Preventive Vaccines
2019-12-31
NMPA has organized the drafting of and released on December 31, 2019 the Guidelines for Adverse Event Classification Standards for Clinical Trials of Preventive Vaccines.
-
NMPA Issued the Administrative Measures for Key Laboratories of NMPA
2020-01-06
NMPA has organized the formulation of and released on January 6,2020 the Administrative Measures for Key Laboratories of NMPA.
